✦ LIBER ✦

Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma

✍ Scribed by Jean-Paul Duong Van Huyen; Sandrine Delignat; Jagadeesh Bayry; Michel D. Kazatchkine; Patrick Bruneval; Antonino Nicoletti; Srini V. Kaveri

Book ID: 116334052
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 216 KB
Volume: 243
Category: Article
ISSN: 0304-3835
DOI: 10.1016/j.canlet.2005.11.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-tumor effect of Coriolus versicolor

Anti-tumor effect of Coriolus versicolor methanol extract against mouse B16 melanoma cells: In vitro and in vivo study

✍ Lj. Harhaji; S. Mijatović; D. Maksimović-Ivanić; I. Stojanović; M. Momčilović; V 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 510 KB

In vivo elimination of CD25+ regulatory

In vivo elimination of CD25+ regulatory T cells leads to tumor rejection of B16F10 melanoma, when combined with interleukin-12 gene transfer

✍ Hiroshi Nagai; Tatsuya Horikawa; Isao Hara; Atsushi Fukunaga; Shuntaro Oniki; Ma 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

In vitro and in vivo effects of an anti-

In vitro and in vivo effects of an anti-mouse endoglin (CD105)–immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours

✍ Raquel Muñoz, Yolanda Arias, José Miguel Ferreras… 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 738 KB

Synergistic anti-tumoral effect of pacli

Synergistic anti-tumoral effect of paclitaxel (taxol)+AS101 in a murine model of B16 melanoma: Association with ras-dependent signal-transduction pathways

✍ Yona Kalechman; Dan L. Longo; Raphael Catane; Adi Shani; Michael Albeck; Benjami 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 206 KB

Optimal doses of paclitaxel (Taxol) combined with the immunomodulator AS101, previously shown to have antitumoral effects, administered to B16 melanoma-bearing mice decreased tumor volume and resulted in over 60% cure. Paclitaxel؉AS101 directly inhibited the clonogenicity of B16 melanoma cells in a

Blocking of interleukin 2 (IL 2) binding

Blocking of interleukin 2 (IL 2) binding to the IL 2 receptor is not required for the in vivo action of anti-IL 2 receptor monoclonal antibody (mAb). I. The production, characterization and in vivo properties of a new mouse anti-rat IL 2 receptor mAb that reacts with an epitope different to the one that binds to IL 2 and the mAb ART-18

✍ Athanasia Mouzaki; Hans-Dieter Volk; Hisao Osawa; Tibor Diamantstein 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 727 KB

A mouse anti-rat interleukin 2 (IL 2) receptor (IL 2R) monoclonal antibody (mAb), ART-65, has been developed. As shown by fluorescence-activated cell sorter analysis and immunoprecipitation studies, ART-65 recognizes in a species-specific manner the same molecule as does ART-18, a mAb which has been